Growth Metrics

Elanco Animal Health (ELAN) Cost of Revenue (2017 - 2026)

Elanco Animal Health's Cost of Revenue history spans 9 years, with the latest figure at $555.0 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 10.78% to $555.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 billion, a 5.94% increase, with the full-year FY2025 number at $2.1 billion, up 5.94% from a year prior.
  • Cost of Revenue hit $555.0 million in Q4 2025 for Elanco Animal Health, up from $530.0 million in the prior quarter.
  • Over the last five years, Cost of Revenue for ELAN hit a ceiling of $566.0 million in Q1 2021 and a floor of $434.0 million in Q2 2023.
  • Historically, Cost of Revenue has averaged $504.9 million across 5 years, with a median of $505.5 million in 2021.
  • The widest YoY moves for Cost of Revenue: up 86.15% in 2021, down 14.46% in 2021.
  • Tracing ELAN's Cost of Revenue over 5 years: stood at $510.0 million in 2021, then dropped by 12.16% to $448.0 million in 2022, then grew by 15.18% to $516.0 million in 2023, then dropped by 2.91% to $501.0 million in 2024, then grew by 10.78% to $555.0 million in 2025.
  • Business Quant data shows Cost of Revenue for ELAN at $555.0 million in Q4 2025, $530.0 million in Q3 2025, and $528.0 million in Q2 2025.